Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT01172938

Public ClinicalTrials.gov record NCT01172938. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis

Study identification

NCT ID
NCT01172938
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
504 participants

Conditions and interventions

Interventions

  • Apremilast 20mg Drug
  • Apremilast 30mg Drug
  • Placebo + 20 mg Apremilast Drug
  • Placebo + 30 mg Apremilast Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2010
Primary completion
Apr 26, 2012
Completion
Oct 26, 2016
Last update posted
Jun 18, 2020

2010 – 2016

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Achieve Clinical Research LLC Birmingham Alabama 35216
Arizona Research Center Phoenix Arizona 85023
UCSD-Thornton Hospital La Jolla California 92093-0943
Stanford University Medical Center Palo Alto California 94304-1808
Inland Rheumatology Clinical Trials Upland California 91786
Arthritis and Rheumatic Disease Specialties Aventura Florida 33180
North Florida Dermatology Jacksonville Florida 32204
Tampa Medical Group Pa Tampa Florida 33614
Sonora Clinical Research, LLC Boise Idaho 83702
Coeur D'Alene Arthritis Clinic Coeur d'Alene Idaho 83814
The Arthritis Center Springfield Illinois 62704
St. Francis Hospital and Health Centers Michigan City Indiana 46360
The Center for Rheumatology and Bone Research Wheaton Maryland 20902
Justus Fiechtner MD PC Lansing Michigan 48910
Physicians East Greenville North Carolina 27834
Carolina Bone and Joint Monroe North Carolina 28112
Piedmont Medical Research Associates Inc Winston-Salem North Carolina 27103-3914
Health Research of Oklahoma Oklahoma City Oklahoma 73103
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Clinical Research Center of Reading, LLP West Reading Pennsylvania 19610
Dermatology Treatment and Research Center Dallas Texas 75230
Accurate Clinical Research Inc Houston Texas 77034
Arthritis and Osteoporosis Associates LLP Lubbock Texas 79424
Center for Clinical Studies Webster Texas 77598
University of Utah Salt Lake City Utah 84132
Seattle Rheumatology Associates Seattle Washington 98104
Arthritis Northwest Rheumatology Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01172938, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2020 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01172938 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →